Wellness tracking has moved into the bathroom: devices that clip to a toilet and watch what you leave behind are on sale, analysing colour, consistency and frequency and sending a report to an app after each visit.
Kohler Health sells its clip‑on tracker for $449 plus $130 for an annual family membership, and Throne’s consumer device is offered for $399 plus $70 as a membership add‑on.
Poo monitor
Wired describes how the devices work: they are sleek white units that attach to the bowl with cameras and sensors positioned to record deposits, specifically designed with cameras facing down.
A light sensor records a short video when you sit; the footage is processed by an algorithm that scores stool and urine for colour, consistency, hydration and other metrics, and an app returns a bathroom‑break report within minutes, Wired reports.
At-home microbiome kit
The companies describes this (without irony) as different from at‑home microbiome kits: rather than issuing a binary healthy‑or‑not verdict, they say the goal is to learn an individual’s baseline and flag changes over time.
For now, however, mainstream gastroenterologists remain cool on the idea that an AI camera adds useful new clinical information for healthy people; Wired spoke to clinicians who suggested the devices are probably unnecessary for routine monitoring.
Automated logging (guffaw)
Startups see a different customer. Throne argues automated logging helps patients with chronic digestive conditions who are supposed to keep stool diaries but do not.
The company also raised $10 million and is developing multispectral imaging it says could detect blood in feces, with a next‑generation model possible within two years.
Kohler says its tracker already alerts users when it detects blood, and both firms emphasise they do not aim to make diagnoses but to nudge users to consult a physician if patterns look abnormal. Critics point out that spotting occasional blood is often benign, and that rigorous comparison with lab tests has not been established.
Money down the loo?
Wired flags privacy and subscription concerns: users pay an up‑front fee and continuing membership for analysis and access to their records. “You’re having to pay time and time again in order to access and analyze your own information,” says Lauren Hendry Parsons in Wired.
This is not an academic prototype anymore; companies are pitching a consumer product at scale into a gut‑health market the firms describe as large and growing.
For people with serious bowel disease, automated, objective logs may be useful.
For the majority, the immediate benefit is thin, and the sensible thing to watch is whether blood‑detection claims are validated in clinical studies and whether the subscription model ends up gating access to one’s own health data.
